Important Information for Investors of Zynex, Inc. (ZYXI): Rosen Law Firm Reminds of Lead Plaintiff Deadline
New York, NY – April 6, 2025
Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Zynex, Inc. (NASDAQ: ZYXI) between March 13, 2023, and March 11, 2025, both dates inclusive (the “Class Period”), of the important May 19, 2025, lead plaintiff deadline. This deadline pertains to a securities class action lawsuit that has been filed against Zynex, Inc. in the United States District Court for the District of Colorado.
What Happened to Zynex, Inc.?
The complaint alleges that during the Class Period, Zynex, Inc. made materially false and/or misleading statements and/or failed to disclose that:
- The company lacked effective internal controls over financial reporting;
- The company’s financial statements contained material misstatements;
- Zynex was experiencing significant growth in its Spinal Cord Stimulation (“SCS”) business due to the sale of certain assets and not organic growth;
- The company’s SCS business was not profitable and was expected to be a drain on the company’s resources for the foreseeable future;
- The company’s SCS business faced significant competition and regulatory challenges;
As a result of these allegations, investors who purchased Zynex securities during the Class Period may have been harmed. The lawsuit seeks to recover damages for investors’ losses.
What Does This Mean for Me?
If you purchased Zynex securities during the Class Period, you may be entitled to compensation without payment of any out-of-pocket fees or costs through a contingency fee arrangement. The lead plaintiff is usually the investor with the largest financial investment in a case. In order to be appointed as lead plaintiff, the Court must determine that the investor is typical of the other class members and that the investor will adequately represent the class. Your ability to share in any recovery is not affected by your status as lead plaintiff or not.
What Does This Mean for the World?
The securities class action lawsuit against Zynex, Inc. is an example of the importance of transparency and accuracy in corporate reporting. It serves as a reminder to companies to ensure that they are providing truthful and complete information to their investors. It also highlights the role of investor rights law firms in protecting the interests of investors and holding companies accountable for their actions.
Conclusion
If you purchased Zynex securities between March 13, 2023, and March 11, 2025, and believe that you have suffered a loss as a result, you may be entitled to compensation. The lead plaintiff deadline in this case is May 19, 2025. Contact Rosen Law Firm to discuss your potential recovery options. The firm represents investors in securities fraud class actions, derivative actions, and individual securities litigation. The firm is dedicated to protecting investors from corporate wrongdoing and securing the maximum compensation for its clients.
This information provided herein may not be applicable in all situations and Rosen Law Firm makes no representations or warranties, express or implied, as to the accuracy or completeness of such information. All information presented herein is subject to change at any time without notice.
Rosen Law Firm
275 Madison Avenue, 34th Floor
New York, NY 10016
Phone: (212) 686-1060
Fax: (212) 202-3827
Email: [email protected]
www.rosenlegal.com
Gary S. Rosen, Esq.
Glenn Silber, Esq.
Phyllis A. Cuttino, Esq.
Kathleen M. Kim, Esq.
Attorneys at Law
